The bill SB1447 introduces new reporting requirements for the sale and transfer of pill tableting and encapsulating machines, mandating that all involved parties, including manufacturers and retailers, submit detailed reports to the Department of Public Safety (DPS) prior to delivery and after payment. It also imposes penalties for non-compliance and increases penalties for unlawful manufacturing of certain substances, reclassifying it from a class 1 misdemeanor to a class 5 felony. Licensed pharmacists are exempt from these reporting requirements when purchasing machines for personal use, as long as they do not resell them to unlicensed entities.

Additionally, the bill amends definitions related to drug offenses, adding new substances to the category of precursor chemicals and establishing specific exemptions for licensed entities like pharmacists and nonprofit medical marijuana dispensaries. It also modifies penalties for repeat offenders of the reporting requirements, changing the classification from a class 1 misdemeanor to a class 6 felony. Overall, the bill aims to strengthen oversight and regulation of machines that could facilitate the illegal production of controlled substances while providing certain exemptions for licensed professionals.

Statutes affected:
Introduced Version: 13-3401, 13-3404.02, 13-3459, 15-712, 32-1901, 13-3422, 4-4, 32-1962, 15-344, 13-3420, 41-617, 15-345, 15-903
Senate Engrossed Version: 13-3401, 13-3404.02, 13-3459, 15-712, 32-1901, 13-3422, 4-4, 32-1962, 15-344, 13-3420, 41-617, 15-345, 15-903
House Engrossed Version: 13-3401, 13-3404.02, 13-3459, 15-712, 32-1901, 13-3422, 4-4, 32-1962, 15-344, 13-3420, 36-2850, 36-2801, 41-617, 15-345, 15-903